FAM90A1

Across TCGA pan-cancer cohorts, FAM90A1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated FAM90A1 data layer compared with 18 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher FAM90A1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FAM90A1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

READ, BRCA, and HNSC are the cancer types where FAM90A1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	All	0.173	0.828	<.001	32	view →
BRCA	OS	Median	III,IV	0.106	0.906	<.001	28	view →
HNSC	OS	Median	IV	0.204	0.641	.020	6	view →
BLCA	OS	Median	All	0.238	0.597	.040	6	view →
UCEC	DFS	Median	II,III,IV	0.922	0.440	.034	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

FAM90A1–READ (OS)

Open the READ breakdown →